Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
117357312 | 11735731 | 2 | F | 201408 | 20160805 | 20151113 | 20160902 | PER | US-JNJFOC-20151005769 | JANSSEN | 62.05 | YR | A | F | Y | 0.00000 | 20160902 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
117357312 | 11735731 | 1 | PS | INVOKANA | CANAGLIFLOZIN | 1 | Oral | Y | N | 204042 | TABLET | ||||||||
117357312 | 11735731 | 2 | SS | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | Y | 0 | TABLET |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
117357312 | 11735731 | 1 | Type 2 diabetes mellitus |
117357312 | 11735731 | 2 | Type 2 diabetes mellitus |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
117357312 | 11735731 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
117357312 | 11735731 | Acute kidney injury |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
117357312 | 11735731 | 1 | 20140311 | 20140921 | 0 | |
117357312 | 11735731 | 2 | 201409 | 0 |